Clinical Trial Update: An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder [Phase 4]

View source ↗

Summary

This is an open-label Phase 4 trial evaluating duloxetine for irritable bowel syndrome with comorbid generalized anxiety disorder. The study has completed and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Irritable Bowel Syndrome

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: West Penn Allegheny Health System | Conditions: Irritable Bowel Syndrome, Generalized Anxiety Disorder | Phase 4 | Status: COMPLETED | Results posted: 2014-07-09